The Impact of Ketone Monoester Intake on Post-exercise Hormonal Responses After Resistance Exercise in Young Males
1 other identifier
interventional
12
1 country
1
Brief Summary
This study investigates how orally ingested exogenous ketone monoester supplements affect circulating hormone concentrations in healthy young adult males after a single session of resistance exercise. Resistance exercise is known to stimulate an acute increase in the circulating concentration of various hormones that are involved in the regulation of muscle mass, including testosterone, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Recently, there has been growing interest in how nutritional supplements impact these natural hormone responses at rest. One such intervention is the oral ingestion of exogenous ketone body supplements. Ketone bodies (i.e., β-hydroxybutyrate (β-HB), acetoacetate (AcAc), and acetone) are naturally occurring compounds that are normally produced by the body during prolonged fasting/starvation, or in response to a "ketogenic" diet (a diet very high in fat and very low in carbohydrates). These ketone body supplements taken in the form of a ketone monoester can quickly raise blood ketone levels without needing to change your diet. Recent research has shown that the ingestion of exogenous ketone supplements or following a 'ketogenic diet' can alter the concentration of certain hormones measured in blood samples at rest. However, the effects of ketone monoester intake on the exercise-induced elevation in circulating hormones is yet to be explored. Therefore, the purpose of this study is to examine how elevated β-HB, induced via the ingestion of the ketone monoester (R)-3-hydroxybutyl-(R)-3-hydroxybutyrate, affects blood concentrations of various anabolic hormones, during post-exercise recovery in healthy young adult males, compared to a placebo drink (flavoured water).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedStudy Start
First participant enrolled
January 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2025
CompletedSeptember 2, 2025
January 1, 2025
7 months
November 8, 2024
August 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Area under the curve for testosterone concentration.
Serum concentration of testosterone (nmol/l) and corresponding area under the curve (AUC), measured at baseline and over 4 hours into the post-exercise recovery period.
Baseline and over 4 hours into the post-exercise recovery period
Time-course data for testosterone concentration.
Serum concentration of testosterone (nmol/l) measured at baseline and at 13 timepoints (t = -60, -45, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180, 240 min).
Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.
Secondary Outcomes (24)
Area under the curve for growth hormone concentration
Baseline and over 4 hours into the post-exercise recovery period
Time-course data for growth hormone concentration.
Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.
Area under the curve for insulin-like growth factor-1 (IGF-1) concentration
Baseline and 4 hours into the post-exercise recovery period
Time-course data for IGF-1 concentration
Baseline, 1 hour pre-exercise and 4-hours during the post-exercise recovery period.
Area under the curve for cortisol concentration.
Baseline and over 4 hours into the post-exercise recovery period.
- +19 more secondary outcomes
Study Arms (2)
Ketone Monoester (KET)
ACTIVE COMPARATORKetone monoester supplement: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate dosed based on participants' body weight (0.36g/kg body weight). The nutritional beverage will be consumed twice: 30 minutes prior to the exercise workout (t = -60 min) and immediately following the completion of the exercise protocol (t = 0 min).
Placebo drink
PLACEBO COMPARATORFlavoured water. Participants will consume this beverage twice: 30 minutes prior to the exercise workout (t = -60 min) and immediately following the completion of the exercise protocol (t = 0 min).
Interventions
Ketone monoester supplement (R)-3-hydroxybutyl (R)-3-hydroxybutyrate based on participants' body weight (0.36g/kg body weight). The ketone brand name: delta G Oxford Ketone Ester.
\- Flavoured water (non-caloric bitter + citrus flavours)
\- 5 sets of 10 repetitions of leg press and 3 sets of 12 repetitions of leg extension/leg curl 'supersets' (1 set of each back to back with no rest in between sets) at 95% of their 10-RM. Between-set rest intervals for the leg exercises will be 60 seconds.
Eligibility Criteria
You may qualify if:
- Healthy adult male participants who are 18-40 years of age (inclusive).
- BMI \>18.5 and \<30.0 kg/m2
- Recreationally active (at least of 150 minutes of activity/week).
You may not qualify if:
- Be willing to entirely avoid alcohol consumption 48 hours prior to the test days.
- Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, be able to understand and read the questionnaires, and carry out all study-related procedures.
- Individuals with metabolic disorders including: Type I or Type II diabetes.
- Individuals with a history of thrombosis / cardiovascular disease, endocrine disorders
- Individuals with knee injuries (i.e., ACL injuries).
- Individuals with a positive medical history of unstable thyroid disease (i.e., hypothyroidism, hyperthyroidism, hyperparathyroidism, and hypoparathyroidism) and immune disorders.
- Individuals who have used tobacco products within the last 6 months.
- Chronic usage of medications known to modulate hormone levels (i.e. corticosteroids and hormone replacement therapy (HRT)) in the last 6 months.
- Current use of ketone supplements or adherence to a ketogenic diet.
- Formal or regular weightlifting activity within the last year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McGill University
Montreal, Quebec, H2W 1S4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tyler Churchward-Venne, PhD
Department of Kinesiology and Physical Education, McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants, Investigators and Outcome Accessors will be blinded to the intervention and control drinks. The drinks will be flavor matched and provided in an opaque bottle. An individual not involved with the study data collection, analysis and interpretation will be designated as a study blinder and randomizer.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 12, 2024
Study Start
January 6, 2025
Primary Completion
July 27, 2025
Study Completion
July 27, 2025
Last Updated
September 2, 2025
Record last verified: 2025-01